News tagged with clinical pharmacology
Effective vaccination against borreliosis possible
"Borreliosis" or "Lyme disease" is caused by the bacterium "Borrelia burgdorferi". In Austria approximately 16,000 people fall ill with borreliosis annually following a tick bite. Roughly every fifth tick in Austria carries ...
Diseases, Conditions, Syndromes
May 14, 2013 |
not rated yet |
0
Researchers study under-recognised and under-treated prothrombotic condition: High platelet reactivity despite treatment
Within the past decade, the variability in pharmacodynamic response and moderate antiplatelet efficacy of clopidogrel has raised major concerns, in particular because it is associated with an increased risk for ischemic events ...
Cardiology
May 06, 2013 |
not rated yet |
0
Mining information contained in clinical notes could yield early signs of harmful drug reactions
Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University ...
Medications
Apr 10, 2013 |
not rated yet |
0
|
Expert panel makes recommendation to government on drugs and driving
An independent panel of experts, including an academic from Queen Mary, University of London, which was tasked by the government to make recommendations regarding drugs and driving, has published its report.
Medications
Mar 08, 2013 |
not rated yet |
0
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
HIV & AIDS
Jan 30, 2013 |
not rated yet |
0
No evidence that doping enhances athletic performance
(HealthDay)—Although use of recombinant human erythropoietin (rHuEPO) is prohibited among athletes because it reportedly enhances performance, there is no scientific evidence that it does so, according ...
Medications
Dec 10, 2012 |
not rated yet |
0
EPO doping in elite cycling: No evidence of benefit, but high risk of harm
The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete's performance and give people who use it an unfair advantage over unenhanced competitors. However a new systemic ...
Health
Dec 05, 2012 |
not rated yet |
0
Immune cells of the brain renew hopes for curing Alzheimer's disease
A new experimental study carried out in mice shows that microglia, immune cells of the brain, might play a key role in protecting the brain from Alzheimer's disease (AD). It is long believed that toxic sticky protein deposits ...
Alzheimer's disease & dementia
Nov 30, 2012 |
4 / 5 (2) |
0
Sustained release naltrexone effective, safe for opioid users
(HealthDay)—Sustained release technologies for administering the opioid antagonist naltrexone (SRX) seem to be effective with an acceptable adverse event profile, according to a review published online ...
Medications
Nov 01, 2012 |
not rated yet |
0
Scientists to study the role genes play in treating tuberculosis
The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis (TB) in Sub-Saharan Africa.
Genetics
Oct 25, 2012 |
not rated yet |
0
|
Protein levels could predict if bowel cancer patients will benefit from Avastin
Comparing levels of specific proteins that the drug Avastin targets could identify patients with advanced bowel cancer who will benefit from the treatment, according to research published in Clinical Cancer Research.
Cancer
Oct 23, 2012 |
not rated yet |
0
Antidepressants, sleeping pills and anxiety drugs may increase driving risk
Drugs prescribed to treat anxiety, depression and insomnia may increase patients' risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based ...
Medications
Sep 12, 2012 |
not rated yet |
1
Designing a new drug for chronic pain
(Medical Xpress)—Scientists at the University of Liverpool and the Royal Liverpool University Hospital have been awarded £1.4 million to design a new drug for the treatment of chronic pain.
Medical research
Aug 24, 2012 |
not rated yet |
0
Low-dose duloxetine deemed safe for urinary incontinence
(HealthDay) -- Duloxetine appears safe for the routine clinical care of women with stress urinary incontinence (SUI), according to a study published online July 23 in the British Journal of Clinical Pharmacology.
Diseases, Conditions, Syndromes
Jul 27, 2012 |
5 / 5 (1) |
0
Hypertension drug does not increase breast cancer risk for women over 55
(Medical Xpress) -- A commonly prescribed medicine used to treat conditions such as heart failure and hypertension does not present women over 55 with any increased risk of breast cancer, a new study at the University of ...
Medications
Jul 23, 2012 |
not rated yet |
0
|
